Archean Chemical Industries Q2 Income Rises 32% on Bromine

Archean Chemical Industries Limited reported 32% year-on-year growth in standalone total income to INR305.4 crore in Q2 FY27, led by a 76% rise in bromine revenue. The September-quarter performance reflected a stronger bromine mix even as industrial salt volumes declined because certain shipments were deferred amid softer PVC and caustic soda market conditions.

What drove Archean Chemical's Q2 FY27 income growth?

Archean Chemical reported standalone total income of INR305.4 crore for Q2 FY27, compared with INR231.8 crore in Q2 FY26. Income was lower than INR332 crore recorded in Q1 FY27, indicating a sequential moderation despite the strong year-on-year increase.

The company reported consolidated total income of INR301.6 crore, up 26% year-on-year from INR240 crore. The difference between standalone and consolidated figures should be considered when comparing reported income measures. Management's operating commentary pointed to product mix and export-led business as important elements of the quarter's performance.

Exports accounted for 79% of quarterly revenue, up from 75% in the corresponding quarter a year earlier. Domestic business represented the remaining 21%. This export share matters because the company sells a substantial part of its output into overseas industrial markets, where demand conditions and shipment schedules can affect quarterly volumes.

How did bromine and industrial salt perform in the quarter?

Bromine was the strongest reported business line, with Q2 FY27 revenue rising 76% year-on-year to INR127 crore. Bromine volumes increased about 29% year-on-year to roughly 4,100 tonnes from 3,160 tonnes, while realisations increased 36% year-on-year and were broadly stable sequentially.

The combination of higher volumes and better realisations lifted bromine's contribution to about 44% of Archean Chemical's quarterly business mix. Its performance was significant because bromine generated nearly half of total standalone income in the quarter, strengthening the contribution from a higher-growth product category.

Industrial salt revenue rose 9% year-on-year to INR161 crore. However, volumes declined 9% to around 812,000 tonnes during the quarter. Management said the company had a solid order book but multiple orders were deferred, largely because of the overall condition of the PVC and caustic soda markets.

Industrial salt remained the largest segment by revenue, accounting for about 55% of the mix. Sulphate of potash, or SOP, accounted for about 1%, underlining that Q2 income was primarily shaped by industrial salt and bromine.

What do the reported margins and business mix indicate?

Archean Chemical reported EBITDA of INR89.3 crore for Q2 FY27, up 17.5% year-on-year and 6.4% sequentially. EBITDA grew more slowly than standalone total income, while the company did not provide a margin figure in the supplied call highlights.

The reported mix helps explain the quarter's financial outcome. Industrial salt supplied the largest revenue share, but bromine expanded much faster and benefited from both volume growth and higher realisations. The company therefore delivered year-on-year income growth despite lower industrial salt dispatches.

Management also referred to positive long-term fundamentals for the global chlor-alkali industry. At the same time, its comments on delayed salt shipments show that near-term industrial demand remains sensitive to conditions in linked PVC and caustic soda markets.

How does the Q2 result matter for investors and operations?

For investors, the key development was the gap between the two main operating segments: bromine revenue climbed 76%, while industrial salt volumes fell 9%. This makes segment-level trends relevant when assessing the sustainability of quarterly income growth rather than relying only on the headline total-income figure.

The quarter also highlighted Archean Chemical's reliance on exports, which contributed 79% of revenue. Export exposure can support access to overseas demand, but it also means shipment timing and conditions in international end-markets can influence reported quarterly performance.

For operations, deferred industrial salt orders did not eliminate the stated order book, but they shifted shipments out of the quarter. Management attributed these deferrals to the PVC and caustic soda environment, rather than reporting a loss of the underlying orders. The future timing of those shipments was not specified in the provided materials.

Conclusion

Archean Chemical's Q2 FY27 results showed that stronger bromine volumes and realisations supported a 32% increase in standalone total income to INR305.4 crore. Industrial salt remained the biggest revenue contributor, but lower shipments limited volume growth in that business despite a reported solid order book.

The next area to watch is the pace at which deferred industrial salt orders are shipped as PVC and caustic soda market conditions develop. Investors will also monitor whether bromine can maintain its reported volume growth and broadly stable sequential realisations in subsequent quarters.